News and Views
Recent Price Movement and Market Context
Sandu Pharmaceuticals has been on a downward trajectory over the past fortnight, with the stock falling 5.38% in the last week, closely mirroring the Sensex’s decline of 5.52%. Over the past month, the stock’s performance remains weak, down 5.46%, although it has outperformed the Sensex’s sharper 9.76% fall during the same period. Year-to-date, the stock has declined 12.10%, slightly better than the Sensex’s 12.50% drop, but the longer-term trend is more concerning. Over one year, Sandu Pharmaceuticals has plummeted 36.85%, in stark contrast to the Sensex’s modest 1.00% gain. The three-year and five-year returns further highlight the stock’s underperformance, with losses of 42.29% over three years compared to the Sensex’s 28.03% gain, ...
Read full news article
